Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)

Clinical trial NCT00405184 · COMPLETED

Trial details

NCT number: NCT00405184
Sponsor: CSL Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immune Deficiency (PID)

Start date: 2007-05-01
Primary completion: 2008-07-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.